IFC has an active portfolio of $3.5 billion in health care companies in emerging markets. Through these investments, IFC helps private providers meet the soaring demand for health care and supports governments in their goal of reaching Universal Health Coverage by 2030. Our investments and advisory services foster best practices in health care and life sciences, promote the deployment of innovative technologies, and advance quality care. IFC also participates in several public-private partnerships in health care.
An interview with Marco Billi on what it takes to succeed in pharma
Innovation is vital to long-term success in the pharmaceutical sector, both for business operations and product development, says Marco Billi, Vice President of International Business and Innovation for Eurofarma, the second largest Brazilian life science manufacturing company and leader in the medical prescription market. Eurofarma, which is an IFC investment client, recently partnered with IFC’s DigiPharma team to develop and implement a digital transformation strategy, enabling the pharmaceutical leader to improve operational efficiency, increase customer satisfaction, and reduce expenses. In an interview, Billi shares the keys to running a successful branded generics company, ways to approach research and development, and where he hopes the company will be later this century.
IFC helps scale up digital delivery of essential services in healthcare.
We use replicable approaches that transfer proven delivery models from one region to another helping clients achieve business results with significant development impact.
The impact of IFC clients in Health and Education in 2021:
- 41.8 MILLIONPATIENTS SERVED
- 284.5ThousandJOBS SUPPORTED
- 153.6ThousandJOBS FOR WOMEN SUPPORTED
A company or entrepreneur seeking to establish a new venture or expand an existing enterprise can approach IFC directly.
The investment proposal can be submitted to the IFC field office that is closest to the location of the proposed project.